The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.
Lingbao Ai, Wan-Ju Kim, Berna Demircan...
https://pubmed.ncbi.nlm.nih.gov/18174247/Actively Recruiting
Led by University of Pittsburgh · Updated on 2026-04-14
256
Participants Needed
1
Research Sites
30 weeks
Total Duration
Chronic wounds that do not heal quickly often have unique genetic signatures. This research aims to study these genetic patterns by analyzing tissue removed from wounds as part of routine care and comparing it with genetic information from blood samples. The goal is to better understand how wound-specific genetic changes affect healing and to explore the role of genetic and epigenetic factors in wound repair. Participants in this observational study will be followed for about 16 weeks. Tissue samples from wound debridement will be collected when possible during standard wound care visits. The study includes four visits at weeks 0, 4, 8, and 16 or earlier if the wound heals sooner. At the first visit, information such as medical history, demographics, and samples of saliva and blood will be collected, along with digital images of the wound. Subsequent visits involve additional imaging, medication reviews, adverse event monitoring, and transepidermal water loss measurements at the final visit. Throughout the study, participants will complete health questionnaires and undergo regular assessments to monitor wound healing progress. Researchers will measure genetic and epigenetic changes in the wound tissue, comparing healing and non-healing phases. The study focuses on identifying key genetic factors that influence healing outcomes. Participation involves multiple visits over several weeks, with ongoing evaluation of tissue samples, imaging, and health status to better understand chronic wound healing.
CONDITIONS
Genetic and Epigenetic Basis of Chronic Wounds
P
Piya Das Ghatak, PhD, MS
S
Sashwati Roy, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Pittsburgh
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 16 weeks (+ or - 2 weeks)
Participants with chronic wounds visiting UPMC hospitals are followed to collect genetic and epigenetic data. Digital imaging, saliva and blood samples, and health questionnaires are collected at scheduled visits.
4 visits at Week 0, Week 4, Week 8, and Week 16 (or earlier if wound heals)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Lingbao Ai, Wan-Ju Kim, Berna Demircan...
https://pubmed.ncbi.nlm.nih.gov/18174247/J Mann, F Oakley, F Akiboye...
https://pubmed.ncbi.nlm.nih.gov/16763620/Finn Gottrup
https://pubmed.ncbi.nlm.nih.gov/15147991/Wei Zhang, Atsushi Shiraishi, Atsushi Suzuki...
https://pubmed.ncbi.nlm.nih.gov/14704912/Andrei V Chernov, Nor Eddine Sounni, Albert G Remacle...
https://pubmed.ncbi.nlm.nih.gov/19286653/Fahimeh Rahnama, Farhad Shafiei, Peter D Gluckman...
https://pubmed.ncbi.nlm.nih.gov/16887905/Dongdong Ti, Meirong Li, Xiaobing Fu...
https://pubmed.ncbi.nlm.nih.gov/24844330/A J Singer, R A Clark
https://pubmed.ncbi.nlm.nih.gov/10471461/Giovanni Crovetti, Giovanna Martinelli, Marwan Issi...
https://pubmed.ncbi.nlm.nih.gov/15062754/Chandan K Sen, Gayle M Gordillo, Sashwati Roy...
https://pubmed.ncbi.nlm.nih.gov/19903300/University of Pittsburgh
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor